Union Korea Pharm Balance Sheet Health
Financial Health criteria checks 3/6
Union Korea Pharm has a total shareholder equity of ₩30.3B and total debt of ₩39.1B, which brings its debt-to-equity ratio to 128.9%. Its total assets and total liabilities are ₩94.4B and ₩64.1B respectively.
Key information
128.9%
Debt to equity ratio
₩39.10b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩7.18b |
| Equity | ₩30.32b |
| Total liabilities | ₩64.10b |
| Total assets | ₩94.43b |
Recent financial health updates
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23
Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27
Recent updates
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27What Percentage Of Union Korea Pharm Co., Ltd. (KOSDAQ:080720) Shares Do Insiders Own?
Dec 22The Union Korea Pharm (KOSDAQ:080720) Share Price Has Gained 38% And Shareholders Are Hoping For More
Nov 17Financial Position Analysis
Short Term Liabilities: A080720's short term assets (₩49.7B) do not cover its short term liabilities (₩59.0B).
Long Term Liabilities: A080720's short term assets (₩49.7B) exceed its long term liabilities (₩5.1B).
Debt to Equity History and Analysis
Debt Level: A080720's net debt to equity ratio (105.3%) is considered high.
Reducing Debt: A080720's debt to equity ratio has increased from 26.1% to 128.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A080720 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A080720 has sufficient cash runway for 1.9 years if free cash flow continues to grow at historical rates of 10.8% each year.